[Clinical aspects of Ebstein's heart anomaly]

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology·2026

Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

European heart journal·2026

Related Experiment Videos

[Clinical aspects of Ebstein's heart anomaly]

Related Concept Videos

Low-power water suppression by hyperbolic secant pulses with controlled offsets and delays (WASHCODE).

Bilirubin and bile acids removal by haemoperfusion through synthetic resin "Persorb".

[A prospective prognostic study of liver cirrhosis].

[Heart catheterization: experience with 1000 examinations].

Depression in spontaneous cell-mediated cytotoxicity occurs during hemodialysis.

Manifestation of radiation injury of human lymphocytes using PHA mitogenic stimulation in different culture systems.

[Growth, development and prediction of body height in children with central precocious puberty after 3 years of therapy with Decapeptyl-Depot, a slow-releasing GnRH agonist].

[Dangers in external treatment of skin diseases in childhood].

[The effect of growth hormone therapy on thyroid parameters].

[Long-term therapy of central precocious puberty in girls with the gonadoliberin analog D-Trp-6-LHRH after prior therapy with cyproterone acetate].

[Improvement in the prognosis for growth in a boy with central precocious puberty and growth hormone deficiency treated concurrently with growth hormone and D-Trp-6-LHRH gonadoliberin analog].

[D-Trp-6 gonadotropin analog releasing hormone (Decapeptyl-Depot)-- the drug of choice in central idiopathic precocious puberty].

Short-Term Anticoagulant Therapy and Subclinical Leaflet Thickening in Transcatheter Aortic Valves: The NOTION-4 Trial.

Effect of colchicine on C-reactive protein level following hospitalization for myocardial infarction: a meta-analysis of randomized, placebo-controlled trials.

Antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation: an individual patient data network meta-analysis.

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis.

Safety of withdrawal of pharmacological treatment after recovery from HER2 therapy-related cardiac dysfunction: the HER-SAFE trial.

Related Experiment Videos

[Clinical aspects of Ebstein's heart anomaly]

Related Concept Videos

Related Articles